[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Michael Kirban, Executive Chairman and Director of Vita Coco Company, Inc. (COCO), reported a sale of common stock under a Rule 10b5-1 trading plan. On 09/11/2025 he disposed of 20,000 shares at a weighted average price of $39.045 (individual sale prices ranged from $39.00 to $39.19). After the reported transaction(s) the filing shows 1,579,049 shares beneficially owned indirectly by Mr. Kirban and additional holdings tied to the Michael Kirban Revocable Trust. The filing also discloses outstanding non-qualified stock options totaling 1,164,490 options across multiple grants with exercise prices ranging from $10.178 to $32.78 and varying vesting and expiration schedules. The sale was executed pursuant to a pre-established plan and the Form 4 was signed by an attorney-in-fact on 09/15/2025.

Positive

• Transaction executed under a Rule 10b5-1 plan, indicating the sale was pre-arranged
• Substantial beneficial ownership remains (1,579,049 shares reported indirectly)
• Extensive option holdings with staggered vesting support continued alignment with shareholders

Negative

• Insider sale of 20,000 shares reduces the reporting person’s economic stake
• Some options have exercise prices below current sale price, implying potential future dilution when exercised

Insights

Corporate Governance Expert

TL;DR: Routine insider sale under a 10b5-1 plan, not an unexpected governance red flag.

The sale of 20,000 shares through a Rule 10b5-1 plan signals a pre-arranged disposition rather than a discretionary, contemporaneous insider trade. The filing confirms substantial indirect beneficial ownership remains with Mr. Kirban and his revocable trust, and multiple option grants remain outstanding with staggered vesting. From a governance perspective, disclosure is complete for the transactions and option holdings shown; there is no indication in the filing of undisclosed related-party or other governance concerns.

Securities Analyst

TL;DR: Insider sold a modest number of shares; material ownership and long-term incentive alignment remain.

The 20,000-share sale at about $39.05 is small relative to the reported indirect ownership of over 1.5 million shares and to the aggregate option positions. The presence of multiple vested and unvested option grants with exercise prices notably below and above the sale price provides continued potential equity exposure and retention incentives. The use of a 10b5-1 plan reduces timing concerns but investors may note the sale when modeling insider liquidity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Kirban Michael

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		S(1)		20,000	D	$39.045(2)	1,579,049	I	by M. Kirban 2010
Common Stock								127,629	D
Common Stock								615,681	I	by M. Kirban Revoc(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(4)	12/16/2029	Common Stock	546,000		546,000	D
Non-Qualified Stock Option (right to buy)	$10.178							(5)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(6)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(7)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(8)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(9)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These shares are held by the Michael Kirban Revocable Trust.

4. The stock option is fully vested and currently exercisable.

5. The stock option is fully vested and currently exercisable.

6. The stock option vests in four equal annual installments beginning on November 27, 2022.

7. The stock option vests in four equal annual installments beginning on March 10, 2024.

8. The stock option vests in four equal annual installments beginning on March 4, 2025.

9. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	By: Alison Klein, Attorney-in-Fact For: Michael Kirban	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Michael Kirban report on Form 4 for COCO?

He reported a sale of 20,000 common shares on 09/11/2025 under a Rule 10b5-1 plan at a weighted average price of $39.045.

How many shares does Michael Kirban beneficially own after the transaction?

1,579,049 shares are reported as beneficially owned indirectly by Mr. Kirban following the reported transaction(s).

Does the Form 4 disclose any stock options for Michael Kirban?

Yes. The filing lists non-qualified stock options totaling 1,164,490 options across multiple grants with exercise prices from $10.178 to $32.78 and various vesting/expiration schedules.

Was the sale discretionary or pre-arranged?

The sale was effected pursuant to a Rule 10b5-1 trading plan, as stated in the filing.

Who signed the Form 4 on behalf of Michael Kirban and when?

Alison Klein, Attorney-in-Fact, signed the Form 4 on 09/15/2025.